← Portfolio Scout

Portfolio company

Neuronostics

United Kingdom · £8.0m raised

Raised

£8.0m

Latest stage

Growth

Rounds recorded

3

Backed by

6 investors

Sectors

Deep TechDigital Health

About

The company develops an EEG-based digital biomarker platform to provide objective diagnostic and prognostic support for epilepsy to healthcare providers and pharmaceutical researchers.

Source

Funding history · 3

Similar companies